Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
(NASDAQ:LQDA), MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss […]